Development and Validation of a Novel TP53 Mutation Signature That Predicts Risk of Metastasis in Primary Prostate Cancer

Overview of attention for article published in Clinical Genitourinary Cancer, August 2020

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age

Mentioned by

twitter: 2 X users

Readers on

mendeley: 18 Mendeley

So far, Altmetric has seen 6 X posts from 2 X users, with an upper bound of 759 followers.

Novel approach. Would be useful in the clinical setting. #cancergenetics #oncology

Development and Validation of a Novel TP53 Mutation Signature That Predicts Risk of Metastasis in Primary Prostate Cancer. https://t.co/zSRYAEiPVf

Development and Validation of a Novel TP53 Mutation Signature That Predicts Risk of Metastasis in Primary Prostate Cancer. https://t.co/zSRYAE1f3H

Development and Validation of a Novel TP53 Mutation Signature That Predicts Risk of Metastasis in Primary Prostate Cancer. https://t.co/zSRYAEiPVf

This page shows the most recent X posts that mention this research output. Click here to find out how to access more activity, including 2 additional X posts.